MINNEAPOLIS, July 27, 2016 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile”) (Nasdaq:TCMD), a medical technology company that develops innovative medical devices for the treatment of chronic diseases at home, announced today the pricing of its initial public offering of 4,000,000 shares of common stock at a public offering price of $10.00 per share.
In addition, Tactile has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of common stock at the public offering price to cover over-allotments, if any. All shares of the common stock in this offering are being sold by Tactile. Tactile’s shares are expected to begin trading on The NASDAQ Global Market on July 28, 2016 under the ticker symbol “TCMD.” This offering is expected to close on August 2, 2016, subject to customary closing conditions.
Piper Jaffray & Co., William Blair & Company, L.L.C., and Canaccord Genuity Inc. are acting as joint book-running managers for the offering. BTIG, LLC is acting as co-manager for the offering.
A registration statement relating to the securities being sold in this offering was declared effective by the U.S. Securities and Exchange Commission on July 27, 2016. This offering is being made only by means of a prospectus. When available, copies of the final prospectus relating to this offering may be obtained by contacting: Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, by telephone at (800) 747-3924, or by email at [email protected], or William Blair & Company L.L.C., Attention: Prospectus Department, 222 West Adams Street, Chicago, IL 60606, by telephone at (800) 621-0867, or by email at [email protected].
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
CONTACT: Investor Inquiries: Mike Piccinino Managing Director Westwicke Partners (443) 213-0500 Media Inquiries: Kristen Weaver Director of Marketing Communications Tactile Medical (612) 355-5116